SOLTIVE Laser vs Ho:YAG Laser for Kidney Stones
(Soltive Stone Trial)
Trial Summary
What is the purpose of this trial?
This trial compares the new SOLTIVE Thulium laser to the traditional Holmium laser for treating kidney stones. The new laser aims to break down stones more efficiently and with less damage to surrounding tissues, potentially improving patient outcomes and reducing costs. The Thulium fibre laser (TFL) has recently been introduced as a new technology and may challenge the Holmium:YAG (Ho:YAG) laser as the preferred option due to its favorable properties.
Research Team
Wilson Molina, MD
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for adults over 18 with a single kidney stone smaller than 2cm who choose to have it removed using ureteroscopy with laser lithotripsy and extraction. It's not for those with stones larger than 2cm, multiple or bilateral stones, or patients preferring natural stone passage.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Ho:YAG Laser (Holmium Laser)
- Percutaneous nephrolithotomy (Procedure)
- SOLTIVE Thulium Fiber Laser (Thulium Laser)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine